PTEN and neoplasm: Loss of PTEN in melanomas promoted resistance to immune infiltration of tumors through the production of inhibitory cytokines, C-C motif chemokine ligand 2 (CCL2) and vascular endothelial growth factor A (VEGF) which contributes to the immunosuppressive tumor microenvironment by recruiting suppressive immune cells [25].